ACIC vs UPC

For growth investors, American Coastal Insurance Corporation (ACIC) is the stronger pick with 13.

1% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). American Coastal Insurance Corporation (ACIC) offers the better valuation at 4. 9x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate American Coastal Insurance Corporation (ACIC) a "Hold" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, American Coastal Insurance Corporation (ACIC) delivered a total return of +98.

5%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: ACIC returned -24. 0% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), American Coastal Insurance Corporation (ACIC) is the lower-risk stock at 0.

39β versus Universe Pharmaceuticals Inc. 's 1. 26β — meaning UPC is approximately 223% more volatile than ACIC relative to the S&P 500. On balance sheet safety, Universe Pharmaceuticals Inc. (UPC) carries a lower debt/equity ratio of 16% versus 48% for American Coastal Insurance Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), American Coastal Insurance Corporation (ACIC) is pulling ahead at 13.

1% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: American Coastal Insurance Corporation grew EPS 40. 5% year-over-year, compared to 26. 5% for Universe Pharmaceuticals Inc.. Over a 3-year CAGR, ACIC leads at 15. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

American Coastal Insurance Corporation (ACIC) is the more profitable company, earning 31.

8% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 31. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACIC leads at 42. 6% versus -16. 3% for UPC. At the gross margin level — before operating expenses — ACIC leads at 86. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, American Coastal Insurance Corporation (ACIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

39)). Both have compounded well over 10 years (ACIC: -24. 0%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ACIC (Financial Services) and UPC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ACIC is a small-cap deep-value stock; UPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.